gene disruption (cont) & protein-protein interactions october 4, 2006 outline recap gene...

45
Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline • Recap • Gene Disruption and Drug Discovery • RNAi • Two Hybrid • Affinity Purification • Protein Chips

Upload: sylvia-allen

Post on 02-Jan-2016

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Gene Disruption (cont) & Protein-Protein Interactions

October 4, 2006

Outline• Recap

• Gene Disruption and Drug Discovery

• RNAi

• Two Hybrid

• Affinity Purification

• Protein Chips

Page 2: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Last Time1) Insertional Mutagenesis

– Transposon Strategies • Use reporter constructs to make enhancer traps and

gene fusions

Gene Traps: Gene Fusion

lacZ--Missing Promotor & ATG

Gene Fusions

2) Systematic KnockoutsBar coded

Page 3: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Yeast Strains With Tagged Knockouts

ORFs onchromosome

TaggedPCR

product

Taggedyeast

strains

Page 4: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Functional Analysis of Knockout Strains

Page 5: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Using Deletions to Profile Drug Sensitivity

Giaever et al. Nature Genetics 1999 vol 21, 278-283

Page 6: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Using Deletions to Profile Drug Sensitivity

ALG7YMR007

Giaever et al. Nature Genetics 1999 vol 21, 278-283

Page 7: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Using Heterozygous Deletions to Profile Drug Sensitivity

(3503 strains 78 Compounds)

Lum et al. Cell 2004 Vol 116

Page 8: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Using Heterozygous Deletions to Profile Drug Sensitivity

(3503 strains)

Lum et al. Cell 2004 Vol 116

Page 9: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

C. elegans RNAi = RNA interference

dsRNA inhibits gene expression

AAAAA

+AA

AA

by degrading its complementary mRNA

dsRNA

mRNA

Fire and Mello 1998 Nature

Page 10: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Genome Wide Approach

Clone genes into E. coli Expression vector that makes dsRNA

ORF

Feed Worm E. coli;Score phenotype

E. coli

Page 11: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

RNAi

16,757 (86%) C. elegans Genes RNAied; 1,722 Mutant phenotypes Ahringer et al., Kohara et al.

Can be used for many organismsDrosophila, Mammalian Cells

Page 12: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Mammalian RNAi Retrovirus Vector

From RNAi consortium

Virus

PackagingCells

Infect Cells

shRNAExpression

Page 13: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Identification of Tumor Suppressors Using RNAiKlofcshoten et al. (2005) Cell 121, 849-858

1° Fibroblasts from humans die

Tr(-onc) Engineered Fibroblasts(hTERT, small t Antigen, p53-, p16-)“almost transformed”

Tr(-onc) Engineered Fibroblasts + RASV12

Transformed and form colonies

Page 14: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Identification of Tumor Suppressors Using RNAi

Klofschoten et al. (2005) Cell 121, 849-858

Tr(-onc) cells

shRNA library (against 4000 genes)

New Tumor Suppressor:PITX1

Page 15: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

RNAi

• Simple and Inexpensive

• Systematic method--Comprehensive

• Knockout expression of gene families

Advantages

Disadvantages• Some Genes Not Affected

• Limited alleles

• Off target effects

Page 16: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Uses of Knockouts: Summary

• Score phenotype to understand gene function

• Group different genes together based on phenotype

• Find new interesting genes

• Drug discovery

Page 17: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Global Protein::Protein Interactions

• Three Methods:

1) Two Hybrid

2) Complex Analysis: Affinity

tagging/Mass Spectroscopy

3) Protein Chip

Page 18: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Two-Hybrid System For DetectingProtein-Protein Interaction

Protein AGal4 DNABinding Domain

Protein BGal4Activation Domain

Genes

FusionProteins

HIS3Gal4 DNABinding Sites Selectable Marker

HIS3 Expression

If A & B interact

Colonies Grow On Plates Lacking

Histidine

Page 19: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Cloning Strategy

ATG TAA

Primer 1 Primer 2Yeast ORFs

GAL

PCR

DBGAL

DB:: ORF

coTransform+ Vector

Page 20: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Screening 6200 X 6200 Interactions

MATa strainsContaining

GalAD construct

Mate to MAT strain Containing DB construct

MATa/MATa Diploids

Assay Expressione.g His+ colonies

HIS3

DB::Protein AFusion

AD::Protein B Fusion

Black = Colonies

Page 21: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Large Scale Two-Hybrid Screening

Sequence Adjacent to ORF for each plasmid (Interaction Sequence Tags ISTs)

Page 22: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Results of Two Studies

1) 4,549 Interactions Among 3,278 Proteins (Ito et al.)

2) 957 Interactions 1004 proteins (Utez et al.)

Page 23: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Interaction Map of Spindle Pole Body (MTOC) Proteins

Page 24: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Interaction Map of Vesicular Transport Proteins

Page 25: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

A Comprehensive Protein Interaction Map

Page 26: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Overlap of the Two Hybrid Studies

541 135 691

69 9

257

Utez et alPool Approach

Ito et alPool Approach

Utez et al. Individual Screen

Page 27: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

8,100 X 8,100 ORFs (~7,200 genes)

(1 DB clone X pool of 188 AD clones)

Human Two Hybrid Screen

10,597 Interactions2,754 Nonredundant

Rual et al. Nature 2005

Page 28: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Human Two Hybrid Map

Rual et al. Nature 2005

Page 29: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Human Two Hybrid Map

Disease Genes

(121 genes (green))

Rual et al. Nature 2005 Vol 437

Page 30: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Two Hybrid

Advantages- In vivo Assay- Fairly Simple

Disadvantages- Hard to execute on a large scale- Prone to artifacts 50% False +s- Interactions mediated in nucleus

Page 31: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Tandem Affinity Purification (TAP) Tagging

ORF Cam-Binding Domain

TEVProtein A

(IgG Binding)

Page 32: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

TAP ApproachIgG Beads

YFP

Contaminants

AssociatedProteins

YFP

Protein A Purification

TEV Protease,CBD Purification Cam

Beads

YFPYFPElute EGTA

Page 33: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Identify Proteins by Mass Spec

Excise Band;Digest with Trypsin;Run Mass Spec

Load on SDS Gel

Page 34: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

TAP Purification of The U1 Splicing Complex (Snu71p)

(New)

(New)

Page 35: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Many Complexes Are Conserved

Page 36: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Affinity Purification/Mass Spec Analysis of Complexes - Yeast

4,562 Purifications (Krogan et al. 2002)2,357 Successful

4,087 Interacting Proteins7,123 Core Interactions (2,708 proteins)14,317 Extended (3,672 proteins)

547 Complexes

Krogan et al. Nature 2006 Vol 440

Page 37: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Two HybridSize and Conservation of the Complexes

Page 38: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

TAP Tag Approach

Advantages- In Vivo Assay- Identifies Entire Complex

Disadvantages- Interactions may be indirect- Likely to miss some rare components- Contaminants may copurify

Page 39: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Summary• Affinity Purification: ~10,000 High Confidence

Interactions Among ~2000 Proteins

• Two Hybrid: >4,549 Interactions Among 3,278 Proteins

• >20,000 Interactions

• Combining Data = More Accuracy

Page 40: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

What is a Protein Microarray?

A high density array containing 100s to many thousands of proteins

Page 41: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

DNA Microarrays

• Analyzing Gene Expression

• Mapping Mutations

• Mapping Transcription Factor Binding Sites

Awesome

Page 42: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

• Protein Function

• Protein Modification and Regulation

• Protein Pathways

• Protein Profiling

• Drug Discovery and Development

Protein Microarrays

Awesome2

Page 43: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Antigens Protein-Protein Interactions

Small Molecule Interactions

ADPATP

EnzymaticAssays

Antibody Microarrays Functional Protein Microarrays

Two Types of Protein Microarrays

Page 44: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Microarray assay of a human serum sample. A 15 µL sample of human serum was incubated for 30 min on a microarray with 75 different anticytokine antibodies printed in quadruplicate. Following washing and incubation with a mixture of secondary antibodies to each cytokine, detection was carried out using RCA. The fluorescent image was obtained using GenePix software on an Axon Microarray Scanner. The enlarged image shown represents one-eighth of the data acquired from a 1' × 3' microscope slide. Fluorescent intensities are represented in pseudocolor, with lowest intensities in blue and highest intensities in white.

Cytokine Detection withAntibody Microarray

Page 45: Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification

Human Allergen Microarray